For how we live.
US guidelines now let women aged 30 to 65 screen every five years with an HPV test. One major body would make that the primary test from age 25 — and self-collected samples work about as well.
Two national studies settle the question the trials could not: in England, cancer rates fell 87% among those vaccinated at 12-13; in Sweden, the risk was cut by nearly two-thirds.
WHO and UNICEF estimates put DTP3 coverage at 85% for a second year running. Yellow fever protection sits at 53% in at-risk countries and HPV at 33% in girls, both far below target.
The year-end immunization summary reports 88% fewer measles deaths since 2000, malaria vaccine in 24 African countries, and 25 years without wild polio in the Western Pacific.
IARC and WHO put five modules on screening and precancer management online. The 90-70-90 targets they support depend on health workers who can act on a positive test.